Business Development Asia LLC
South East Asian Health News
ISSUE 3, OCTOBER 1997
INDONESIA
Bio Farma, a leading Indonesian pharmaceutical manufacturer, is set to export 55 million units of anti-polio vaccines through the WHO. According to Dr. Steven Rosenthal, medical officer for the WHO, Indonesia has the best organized immunization program among developing nations. Since 1992, Bio Farma has produced 80 million anti-polio vaccine units, while consumption in Indonesia is only 25 million per year. Last year, Bio Farma exported its anti-polio vaccine surpluses independently. Starting this year, it will export the vaccines through the WHO. (September 3rd 1997)
The Indonesian Government has announced plans to liberalize the medical sector in 2003. The private sector will be encouraged to play a larger role because the Government cannot alone meet the growing demands for healthcare and for higher standards. Liberalization should attract investments in its hospitals, clinics and laboratories and draw in more specialists. (August 1st 1997)
PT Meiji Indonesian Pharmaceutical Industries, a subsidiary of the Japanese Meiji Seika Kaisha, has signed a production contract to produce five of Takeda Chemical Industries' penicillin-based antibiotics. Takeda will halt its Japanese production of the five drugs (melysin, lilacillin, solcillin, amolin, and vasticillin) and has applied for permission to import them into Japan from Indonesia. (August 29th 1997)
PT Purayashuma Sakti and PT Garama Adipratama Mulia are to establish a JV with Recon Ltd., a leading pharmaceutical company based in India, to manufacture antibiotics and drugs for the Indonesian market. The new JV, PT Recon Pharmagriya, has a project cost of Rp16bn (US$5.5m). Construction is expected to start in September 1997. (August 28th 1997)
PT Sido Muncul, a manufacturer of traditional herbal 'Jamu' medicine, stated that has revenues of Rp300m (US$100,000) per month from exporting Jamu to other ASEAN countries. Despite competition from Chinese herbal medicines and other medications from the US and Australia, Sido Muncul plans to increase Jamu exports to Malaysia, Singapore, and Brunei to meet rising demand. (August 25th 1997)
PT Sinkona Indonesian Lestari (SIL) and PT Kimia Farma, the principal producers of quinine and quinine sulphate in Indonesia, will increase their production capacity to meet rising international demand. Quinine is used to counter malaria and used in cosmetics, soft drinks and other chemical industries. With state-owned plantations increasing the supply of quinine bark, Indonesian producers should be able to compete more effectively against the German companies who hold 50% of the current market share. PT SIL's current production capacity is 100 tons per annum. (September 3rd 1997)
Rohto Pharmaceutical Co. of Japan has begun production and sales of therapeutic lenses for cataracts and eyedrops in Indonesia. (August 28th 1997)
Recent News: Malaysia, Philippines, Thailand, Singapore, Regional, Regional Focus: Malaysia: an increasingly entrepreneurial health sector
Business Development Asia LLC, The Economist Building,
111 West 57th Street, Suite 405, New York, NY 10019
Tel (212) 265 5300 Fax (212) 265 4300 E-mail bdallc@aol.com
A limited liability company incorporated in the State of DelawareHome | Introduction | Services | Skills | Management | Contact | Newsletters